An Evaluation Of Immatics N.V (NASDAQ: IMTX) Prospects

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.

Stocks Info

IMTX belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Immatics N.V is $655.16M. A total of 0.58 million shares were traded on the day, compared to an average of 658.76K shares.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, IMTX has a high of $13.77 and a low of $3.30.

As of this writing, IMTX has an earnings estimate of -$0.36 per share for the current quarter. EPS was calculated based on a consensus of 3.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.41.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. IMTX’s latest balance sheet shows that the firm has $145.12M in Cash & Short Term Investments as of fiscal 2021. There were $9.85M in debt and $95.15M in liabilities at the time. Its Book Value Per Share was $4.77, while its Total Shareholder’s Equity was $24.06M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMTX is Buy with a score of 5.00.

Related Posts

Park Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.